line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-3535200.0,TRIGYN.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,TRIGYN.NS
Normalized EBITDA,2025-03-31 00:00:00,354305000.0,TRIGYN.NS
Total Unusual Items,2025-03-31 00:00:00,-11784000.0,TRIGYN.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-11784000.0,TRIGYN.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Reconciled Depreciation,2025-03-31 00:00:00,50098000.0,TRIGYN.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,4847301000.0,TRIGYN.NS
EBITDA,2025-03-31 00:00:00,342521000.0,TRIGYN.NS
EBIT,2025-03-31 00:00:00,292423000.0,TRIGYN.NS
Net Interest Income,2025-03-31 00:00:00,-27759000.0,TRIGYN.NS
Interest Expense,2025-03-31 00:00:00,27759000.0,TRIGYN.NS
Interest Income,2025-03-31 00:00:00,,TRIGYN.NS
Normalized Income,2025-03-31 00:00:00,125942800.0,TRIGYN.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Total Expenses,2025-03-31 00:00:00,8853703000.0,TRIGYN.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,TRIGYN.NS
Diluted Average Shares,2025-03-31 00:00:00,30809948.0,TRIGYN.NS
Basic Average Shares,2025-03-31 00:00:00,30809948.0,TRIGYN.NS
Diluted EPS,2025-03-31 00:00:00,3.82,TRIGYN.NS
Basic EPS,2025-03-31 00:00:00,3.82,TRIGYN.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Net Income Common Stockholders,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,TRIGYN.NS
Net Income,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,,TRIGYN.NS
Net Income Continuous Operations,2025-03-31 00:00:00,117694000.0,TRIGYN.NS
Tax Provision,2025-03-31 00:00:00,146970000.0,TRIGYN.NS
Pretax Income,2025-03-31 00:00:00,264664000.0,TRIGYN.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,177394000.0,TRIGYN.NS
Special Income Charges,2025-03-31 00:00:00,-11784000.0,TRIGYN.NS
Write Off,2025-03-31 00:00:00,,TRIGYN.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-27759000.0,TRIGYN.NS
Total Other Finance Cost,2025-03-31 00:00:00,,TRIGYN.NS
Interest Expense Non Operating,2025-03-31 00:00:00,27759000.0,TRIGYN.NS
Interest Income Non Operating,2025-03-31 00:00:00,,TRIGYN.NS
Operating Income,2025-03-31 00:00:00,126815000.0,TRIGYN.NS
Operating Expense,2025-03-31 00:00:00,4006402000.0,TRIGYN.NS
Other Operating Expenses,2025-03-31 00:00:00,3956304000.0,TRIGYN.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,50098000.0,TRIGYN.NS
Amortization,2025-03-31 00:00:00,,TRIGYN.NS
Depreciation Income Statement,2025-03-31 00:00:00,50098000.0,TRIGYN.NS
Selling General And Administration,2025-03-31 00:00:00,,TRIGYN.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,TRIGYN.NS
General And Administrative Expense,2025-03-31 00:00:00,,TRIGYN.NS
Rent And Landing Fees,2025-03-31 00:00:00,,TRIGYN.NS
Gross Profit,2025-03-31 00:00:00,4133217000.0,TRIGYN.NS
Cost Of Revenue,2025-03-31 00:00:00,4847301000.0,TRIGYN.NS
Total Revenue,2025-03-31 00:00:00,8980518000.0,TRIGYN.NS
Operating Revenue,2025-03-31 00:00:00,8980518000.0,TRIGYN.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,TRIGYN.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,TRIGYN.NS
Normalized EBITDA,2024-03-31 00:00:00,467445000.0,TRIGYN.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,TRIGYN.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,TRIGYN.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Reconciled Depreciation,2024-03-31 00:00:00,68768000.0,TRIGYN.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,8152752000.0,TRIGYN.NS
EBITDA,2024-03-31 00:00:00,467445000.0,TRIGYN.NS
EBIT,2024-03-31 00:00:00,398677000.0,TRIGYN.NS
Net Interest Income,2024-03-31 00:00:00,-16571000.0,TRIGYN.NS
Interest Expense,2024-03-31 00:00:00,16571000.0,TRIGYN.NS
Interest Income,2024-03-31 00:00:00,47337000.0,TRIGYN.NS
Normalized Income,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Total Expenses,2024-03-31 00:00:00,12517876000.0,TRIGYN.NS
Rent Expense Supplemental,2024-03-31 00:00:00,9738000.0,TRIGYN.NS
Diluted Average Shares,2024-03-31 00:00:00,30807562.0,TRIGYN.NS
Basic Average Shares,2024-03-31 00:00:00,30807562.0,TRIGYN.NS
Diluted EPS,2024-03-31 00:00:00,6.48,TRIGYN.NS
Basic EPS,2024-03-31 00:00:00,6.48,TRIGYN.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Net Income Common Stockholders,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,TRIGYN.NS
Net Income,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,,TRIGYN.NS
Net Income Continuous Operations,2024-03-31 00:00:00,199633000.0,TRIGYN.NS
Tax Provision,2024-03-31 00:00:00,182473000.0,TRIGYN.NS
Pretax Income,2024-03-31 00:00:00,382106000.0,TRIGYN.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,119930000.0,TRIGYN.NS
Special Income Charges,2024-03-31 00:00:00,0.0,TRIGYN.NS
Write Off,2024-03-31 00:00:00,,TRIGYN.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-16571000.0,TRIGYN.NS
Total Other Finance Cost,2024-03-31 00:00:00,6697000.0,TRIGYN.NS
Interest Expense Non Operating,2024-03-31 00:00:00,16571000.0,TRIGYN.NS
Interest Income Non Operating,2024-03-31 00:00:00,47337000.0,TRIGYN.NS
Operating Income,2024-03-31 00:00:00,278747000.0,TRIGYN.NS
Operating Expense,2024-03-31 00:00:00,4365124000.0,TRIGYN.NS
Other Operating Expenses,2024-03-31 00:00:00,4296356000.0,TRIGYN.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,68768000.0,TRIGYN.NS
Amortization,2024-03-31 00:00:00,31928000.0,TRIGYN.NS
Depreciation Income Statement,2024-03-31 00:00:00,68768000.0,TRIGYN.NS
Selling General And Administration,2024-03-31 00:00:00,3426710000.0,TRIGYN.NS
Selling And Marketing Expense,2024-03-31 00:00:00,1789000.0,TRIGYN.NS
General And Administrative Expense,2024-03-31 00:00:00,3424921000.0,TRIGYN.NS
Rent And Landing Fees,2024-03-31 00:00:00,9738000.0,TRIGYN.NS
Gross Profit,2024-03-31 00:00:00,4643871000.0,TRIGYN.NS
Cost Of Revenue,2024-03-31 00:00:00,8152752000.0,TRIGYN.NS
Total Revenue,2024-03-31 00:00:00,12796623000.0,TRIGYN.NS
Operating Revenue,2024-03-31 00:00:00,12796623000.0,TRIGYN.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,TRIGYN.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,TRIGYN.NS
Normalized EBITDA,2023-03-31 00:00:00,660728000.0,TRIGYN.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,TRIGYN.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,TRIGYN.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Reconciled Depreciation,2023-03-31 00:00:00,68019000.0,TRIGYN.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,7935590000.0,TRIGYN.NS
EBITDA,2023-03-31 00:00:00,660728000.0,TRIGYN.NS
EBIT,2023-03-31 00:00:00,592709000.0,TRIGYN.NS
Net Interest Income,2023-03-31 00:00:00,27638000.0,TRIGYN.NS
Interest Expense,2023-03-31 00:00:00,10359000.0,TRIGYN.NS
Interest Income,2023-03-31 00:00:00,50060000.0,TRIGYN.NS
Normalized Income,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Total Expenses,2023-03-31 00:00:00,12169270000.0,TRIGYN.NS
Rent Expense Supplemental,2023-03-31 00:00:00,14635000.0,TRIGYN.NS
Diluted Average Shares,2023-03-31 00:00:00,30786000.0,TRIGYN.NS
Basic Average Shares,2023-03-31 00:00:00,30786000.0,TRIGYN.NS
Diluted EPS,2023-03-31 00:00:00,11.26,TRIGYN.NS
Basic EPS,2023-03-31 00:00:00,11.26,TRIGYN.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Net Income Common Stockholders,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,TRIGYN.NS
Net Income,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,,TRIGYN.NS
Net Income Continuous Operations,2023-03-31 00:00:00,346772000.0,TRIGYN.NS
Tax Provision,2023-03-31 00:00:00,235578000.0,TRIGYN.NS
Pretax Income,2023-03-31 00:00:00,582350000.0,TRIGYN.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,2980000.0,TRIGYN.NS
Special Income Charges,2023-03-31 00:00:00,0.0,TRIGYN.NS
Write Off,2023-03-31 00:00:00,0.0,TRIGYN.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,27638000.0,TRIGYN.NS
Total Other Finance Cost,2023-03-31 00:00:00,12063000.0,TRIGYN.NS
Interest Expense Non Operating,2023-03-31 00:00:00,10359000.0,TRIGYN.NS
Interest Income Non Operating,2023-03-31 00:00:00,50060000.0,TRIGYN.NS
Operating Income,2023-03-31 00:00:00,557974000.0,TRIGYN.NS
Operating Expense,2023-03-31 00:00:00,4233680000.0,TRIGYN.NS
Other Operating Expenses,2023-03-31 00:00:00,486373000.0,TRIGYN.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,68019000.0,TRIGYN.NS
Amortization,2023-03-31 00:00:00,35835000.0,TRIGYN.NS
Depreciation Income Statement,2023-03-31 00:00:00,32184000.0,TRIGYN.NS
Selling General And Administration,2023-03-31 00:00:00,3143929000.0,TRIGYN.NS
Selling And Marketing Expense,2023-03-31 00:00:00,4053000.0,TRIGYN.NS
General And Administrative Expense,2023-03-31 00:00:00,3139876000.0,TRIGYN.NS
Rent And Landing Fees,2023-03-31 00:00:00,14635000.0,TRIGYN.NS
Gross Profit,2023-03-31 00:00:00,4791654000.0,TRIGYN.NS
Cost Of Revenue,2023-03-31 00:00:00,7935590000.0,TRIGYN.NS
Total Revenue,2023-03-31 00:00:00,12727244000.0,TRIGYN.NS
Operating Revenue,2023-03-31 00:00:00,12727244000.0,TRIGYN.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-125601.635939,TRIGYN.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.335833,TRIGYN.NS
Normalized EBITDA,2022-03-31 00:00:00,671726000.0,TRIGYN.NS
Total Unusual Items,2022-03-31 00:00:00,-374000.0,TRIGYN.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-374000.0,TRIGYN.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Reconciled Depreciation,2022-03-31 00:00:00,67008000.0,TRIGYN.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,6746084000.0,TRIGYN.NS
EBITDA,2022-03-31 00:00:00,671352000.0,TRIGYN.NS
EBIT,2022-03-31 00:00:00,604344000.0,TRIGYN.NS
Net Interest Income,2022-03-31 00:00:00,-18407000.0,TRIGYN.NS
Interest Expense,2022-03-31 00:00:00,16058000.0,TRIGYN.NS
Interest Income,2022-03-31 00:00:00,9255000.0,TRIGYN.NS
Normalized Income,2022-03-31 00:00:00,390968398.364061,TRIGYN.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Total Expenses,2022-03-31 00:00:00,9814411000.0,TRIGYN.NS
Rent Expense Supplemental,2022-03-31 00:00:00,11741000.0,TRIGYN.NS
Diluted Average Shares,2022-03-31 00:00:00,30786000.0,TRIGYN.NS
Basic Average Shares,2022-03-31 00:00:00,30786000.0,TRIGYN.NS
Diluted EPS,2022-03-31 00:00:00,12.69,TRIGYN.NS
Basic EPS,2022-03-31 00:00:00,12.69,TRIGYN.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Net Income Common Stockholders,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,TRIGYN.NS
Net Income,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,TRIGYN.NS
Net Income Continuous Operations,2022-03-31 00:00:00,390720000.0,TRIGYN.NS
Tax Provision,2022-03-31 00:00:00,197566000.0,TRIGYN.NS
Pretax Income,2022-03-31 00:00:00,588286000.0,TRIGYN.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,14107000.0,TRIGYN.NS
Special Income Charges,2022-03-31 00:00:00,-374000.0,TRIGYN.NS
Write Off,2022-03-31 00:00:00,374000.0,TRIGYN.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-18407000.0,TRIGYN.NS
Total Other Finance Cost,2022-03-31 00:00:00,11604000.0,TRIGYN.NS
Interest Expense Non Operating,2022-03-31 00:00:00,16058000.0,TRIGYN.NS
Interest Income Non Operating,2022-03-31 00:00:00,9255000.0,TRIGYN.NS
Operating Income,2022-03-31 00:00:00,591424000.0,TRIGYN.NS
Operating Expense,2022-03-31 00:00:00,3068327000.0,TRIGYN.NS
Other Operating Expenses,2022-03-31 00:00:00,203233000.0,TRIGYN.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,67008000.0,TRIGYN.NS
Amortization,2022-03-31 00:00:00,39439000.0,TRIGYN.NS
Depreciation Income Statement,2022-03-31 00:00:00,27569000.0,TRIGYN.NS
Selling General And Administration,2022-03-31 00:00:00,2343415000.0,TRIGYN.NS
Selling And Marketing Expense,2022-03-31 00:00:00,2418000.0,TRIGYN.NS
General And Administrative Expense,2022-03-31 00:00:00,2340997000.0,TRIGYN.NS
Rent And Landing Fees,2022-03-31 00:00:00,11741000.0,TRIGYN.NS
Gross Profit,2022-03-31 00:00:00,3659751000.0,TRIGYN.NS
Cost Of Revenue,2022-03-31 00:00:00,6746084000.0,TRIGYN.NS
Total Revenue,2022-03-31 00:00:00,10405835000.0,TRIGYN.NS
Operating Revenue,2022-03-31 00:00:00,10405835000.0,TRIGYN.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,TRIGYN.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,TRIGYN.NS
Normalized EBITDA,2021-03-31 00:00:00,,TRIGYN.NS
Total Unusual Items,2021-03-31 00:00:00,,TRIGYN.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,TRIGYN.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,TRIGYN.NS
Reconciled Depreciation,2021-03-31 00:00:00,,TRIGYN.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,TRIGYN.NS
EBITDA,2021-03-31 00:00:00,,TRIGYN.NS
EBIT,2021-03-31 00:00:00,,TRIGYN.NS
Net Interest Income,2021-03-31 00:00:00,,TRIGYN.NS
Interest Expense,2021-03-31 00:00:00,,TRIGYN.NS
Interest Income,2021-03-31 00:00:00,17758000.0,TRIGYN.NS
Normalized Income,2021-03-31 00:00:00,,TRIGYN.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,TRIGYN.NS
Total Expenses,2021-03-31 00:00:00,,TRIGYN.NS
Rent Expense Supplemental,2021-03-31 00:00:00,13097000.0,TRIGYN.NS
Diluted Average Shares,2021-03-31 00:00:00,,TRIGYN.NS
Basic Average Shares,2021-03-31 00:00:00,,TRIGYN.NS
Diluted EPS,2021-03-31 00:00:00,,TRIGYN.NS
Basic EPS,2021-03-31 00:00:00,,TRIGYN.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,TRIGYN.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,TRIGYN.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,TRIGYN.NS
Net Income,2021-03-31 00:00:00,,TRIGYN.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,TRIGYN.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,0.0,TRIGYN.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,TRIGYN.NS
Tax Provision,2021-03-31 00:00:00,,TRIGYN.NS
Pretax Income,2021-03-31 00:00:00,,TRIGYN.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,TRIGYN.NS
Special Income Charges,2021-03-31 00:00:00,,TRIGYN.NS
Write Off,2021-03-31 00:00:00,3635000.0,TRIGYN.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,TRIGYN.NS
Total Other Finance Cost,2021-03-31 00:00:00,9328000.0,TRIGYN.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,TRIGYN.NS
Interest Income Non Operating,2021-03-31 00:00:00,17758000.0,TRIGYN.NS
Operating Income,2021-03-31 00:00:00,,TRIGYN.NS
Operating Expense,2021-03-31 00:00:00,,TRIGYN.NS
Other Operating Expenses,2021-03-31 00:00:00,,TRIGYN.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,TRIGYN.NS
Amortization,2021-03-31 00:00:00,,TRIGYN.NS
Depreciation Income Statement,2021-03-31 00:00:00,,TRIGYN.NS
Selling General And Administration,2021-03-31 00:00:00,1990320000.0,TRIGYN.NS
Selling And Marketing Expense,2021-03-31 00:00:00,1424000.0,TRIGYN.NS
General And Administrative Expense,2021-03-31 00:00:00,1988896000.0,TRIGYN.NS
Rent And Landing Fees,2021-03-31 00:00:00,13097000.0,TRIGYN.NS
Gross Profit,2021-03-31 00:00:00,,TRIGYN.NS
Cost Of Revenue,2021-03-31 00:00:00,,TRIGYN.NS
Total Revenue,2021-03-31 00:00:00,,TRIGYN.NS
Operating Revenue,2021-03-31 00:00:00,,TRIGYN.NS
